2019 Speaker Lineup


  • Tara Arvedson, PhD, Director, Oncology Research, Amgen

  • John Babcook, PhD, Senior Vice President, Discovery Research, Zymeworks

  • H. Kaspar Binz, PhD, CEO & Founder, Binz Biotech Consulting

  • Ulrich Brinkmann, PhD, Expert Scientist, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, FRG

  • Nazzareno Dimasi, PhD, Associate Director, R&D, AstraZeneca Biopharmaceuticals

  • Rakesh Dixit, PhD, DABT Vice President, AstraZeneca Biopharmaceuticals

  • Diego Ellerman, PhD, Principal Scientific Researcher, Genentech

  • Soldano Ferrone, MD, PhD, Professor in Residence, Surgical Oncology, Surgery, Massachusetts General Hospital, Harvard Medical School

  • Tariq Ghayur, PhD, Distinguished Research Fellow, Immunology Discovery, AbbVie

  • Stefan Grüner, PhD, Scientist, Molecular Biology and Protein Engineering, Pieris Pharmaceuticals

  • Bonnie Hammer, PhD, Vice President, Biologic Development, Invenra

  • Sang Hoon Lee, PhD, CEO, ABL Bio

  • Ping Ji, PhD, Pharmacologist, OCP, FDA

  • Bin Liu, PhD, Professor, Anesthesia, University of California, San Francisco

  • Yariv Mazor, PhD, Senior Scientist, Antibody Discovery & Protein Engineering, AstraZeneca Biopharmaceuticals

  • Paul A. Moore, PhD, Vice President, Cell Biology & Immunology, MacroGenics, Inc.

  • Tom Moore, PhD, Project Team Leader, Early Development, Roche

  • Maria Karasarides, PhD, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

  • Roland E. Kontermann, PhD, Professor, Institute of Cell Biology and Immunology, Stuttgart Research Center Systems Biology, University of Stuttgart

  • Umesh S. Muchhal, PhD, Director, Protein Sciences, Xencor, Inc.

  • Kate Peng, PhD, Group Leader/Senior Scientist, BioAnalytical Sciences, Genentech

  • G. Jonah Rainey, PhD, Vice President, Antibody Therapeutics, Gritstone Oncology

  • Oliver Seifert, PhD, Senior Scientist, Institute of Cell Biology and Immunology, University of Stuttgart

  • Julius Strauss, MD, Assistant Research Physician, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, NCI, NIH

  • Nathan Trinklein, PhD, Vice President, Discovery Research, Teneobio

  • David Urech, PhD, CEO, CSO, Numab Therapeutics AG

  • Wen Jin Wu, MD, PhD, Senior Investigator, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA CDER

  • Yanli Yang, PhD, Senior Scientific Researcher, Antibody Engineering Department, Genentech



short-courses

posters

sponsors

c1

c2